Spinocerebellar Ataxia
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Spinocerebellar Ataxia

View Main Condition: Movement Disorders

What is the definition of Spinocerebellar Ataxia?
Spinocerebellar ataxia is a genetic disorder that has many different types. Ataxia is a term that refers to difficulties with movement, balance, coordination, and speech. Spinocerebellar ataxia can appear at any age and is a progressive disorder.
What are the symptoms of Spinocerebellar Ataxia?
Symptoms of spinocerebellar ataxia depend on the type. Symptoms of spinocerebellar ataxia may appear suddenly or develop over time. Common symptoms of spinocerebellar ataxia include weakness, loss of sensation, and difficulty with eye movements. Additional symptoms of spinocerebellar ataxia may include back-and-forth eye movements, clumsiness, slurred speech, difficulty swallowing, loss of fine motor skills, muscle tremors, decreased coordination, difficulty walking, wide-set gait, impaired balance, frequent falls, and heart problems.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Spinocerebellar Ataxia?
There is currently no cure for spinocerebellar ataxia. Treatment for spinocerebellar ataxia depends on the type. Treatment for spinocerebellar ataxia is focused on managing the symptoms and improving mobility. Treatments for symptoms of spinocerebellar ataxia may include medications; physical therapy; occupational therapy; speech therapy; and assistive mobility devices, such as modified eating utensils, communication aids, canes, hiking sticks, walker, wheelchair, or motorized scooter.
Who are the top Spinocerebellar Ataxia Local Doctors?
Elite in Spinocerebellar Ataxia
Elite in Spinocerebellar Ataxia
Referral may be required

East Ann Arbor Health & Geriatrics Center

4260 Plymouth Rd, Level 1, 
Ann Arbor, MI 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Henry Paulson is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Paulson is rated as an Elite provider by MediFind in the treatment of Spinocerebellar Ataxia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology. Dr. Paulson is currently accepting new patients.

Elite in Spinocerebellar Ataxia
Elite in Spinocerebellar Ataxia
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Christopher Gomez is a Neurologist practicing medicine in Chicago, Illinois. Dr. Gomez is rated as an Elite provider by MediFind in the treatment of Spinocerebellar Ataxia. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia, Olivopontocerebellar Atrophy, Acute Cerebellar Ataxia, Gastrostomy, and Stent Placement. Dr. Gomez is board certified in Neurology and Practicing Since1990. Dr. Gomez is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spinocerebellar Ataxia
Neurology
Elite in Spinocerebellar Ataxia
Neurology
Referral may be required
259 E Erie St Ste 1900, Lavin Family Pavilion, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Puneet Opal is a Neurologist practicing medicine in Chicago, Illinois. Dr. Opal is rated as an Elite provider by MediFind in the treatment of Spinocerebellar Ataxia. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 1, Olivopontocerebellar Atrophy, Giant Axonal Neuropathy, and Spinocerebellar Ataxia. Dr. Opal is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified). Dr. Opal is currently accepting new patients.

What are the latest Spinocerebellar Ataxia Clinical Trials?
Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study

Summary: A pivotal, randomized, double-blind, placebo-controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of CACNA1A. The objective of this study is to evaluate the safety, tolerability and efficacy of N-acetyl-L-leucine (IB1001) compared to standard of care.

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, Pharmacodynamics, Pharmacokinetics, and Tolerability of Subcutaneous CTI-1601 in Subjects With Friedreich's Ataxia

Summary: An open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of CTI-1601 enrolling adolescent and adult patients with FRDA who have participated in a prior clinical study of CTI-1601 as well as children (age 2 years and older), adolescents and adults with FRDA who have not participated in a prior clinical study of CTI-1601.